COVID-19 VACCINE ELIGIBILITY & mRNA SCHEDULE, PROOF of VACCINATION and VACCINE FINDER
All people in Manitoba aged 6 months and older are eligible for COVID-19 vaccination.
Vaccines are the best defense against the COVID-19 virus. Individuals are encouraged to get vaccinated as soon as they are eligible and ensure they receive all the doses recommended for the best protection.
The vaccine is available from medical clinics, pharmacies and other locations. Use the Vaccine Finder to find a convenient location. You can make your vaccine appointment at some sites online or by calling 1-844-626-8222.
On this page:
- XBB.1.5 Vaccine Eligibility
- Vaccine Eligibility for Children aged 6 months to 4 years
- Vaccine Eligibility for Individuals aged 5 years and Older
- Vaccine Eligibility for Infants, Children, Youth and Adults who are Moderately to Severely Immunocompromised
- Immunization after a COVID-19 infection
- Organizing a Workplace Clinic
- Canadian Proof of Vaccination Credential and Immunization records
- Vaccine finder
XBB.1.5 Vaccine Eligibility
Updated formulations of the COVID-19 mRNA vaccines have been developed to protect against the XBB.1.5 strain of the COVID-19 virus. They have been approved for use in:
- Individuals age 6 months and older who have never received a COVID-19 vaccine.
- Individuals age 6 months and older who have already received a COVID-19 vaccine and need one or more additional doses to complete their primary series.
- Individuals age 6 months and older who have completed a primary series with COVID-19 vaccines and are recommended to receive an additional dose for fall 2023.
Vaccine Eligibility for Children aged 6 months to 4 years
Children 6 months to 4 years of age who have never been vaccinated against COVID-19 are eligible to receive two or three doses depending on the vaccine product. Children must be at least six months of age at the time of their immunization appointment.
There are two products authorized for children 6 months to 4 years:
- Moderna: The primary series consists of 2 doses. The minimum interval between the first and second dose is four weeks.
- Pfizer: The primary series consists of 3 doses
Individuals who started their primary series with the original monovalent or bivalent vaccines can complete their primary series with the updated XBB.1.5 formulation. Regardless of which product was used to start a primary series, the previous dose(s) should be counted and the series need not be restarted.
Beginning in the fall of 2023 for those previously vaccinated against COVID-19, individuals aged 6 months and older are recommended to receive a dose of the new formulation of COVID-19 vaccine if it has been at least 6 months from the previous COVID-19 vaccine dose or known SARS-CoV-2 infection (whichever is later).
|
|
Approved COVID-19 mRNA vaccine for primary series |
Time between doses of primary series/# of doses |
Time between last dose received and additional dose |
Approved COVID-19 mRNA vaccines for additional doses for fall 2023 |
|
Infants and children aged |
Moderna/Spikevax™ XBB.1.5 (25mcg) or Pfizer/Comirnaty™ (3mcg) |
Moderna: minimum 4 weeks/ 2 doses
Pfizer: usually 8 weeks/ 3 doses |
6 months |
Moderna/Spikevax™ XBB.1.5 (25mcg) |
For more information on the National Advisory Committee on Immunization (NACI) recommendations, please go to the Canadian Immunization Guide.
Vaccine Eligibility for Individuals aged 5 years and Older
Individuals 5 years and older who have never been vaccinated against COVID-19 are eligible to receive one dose of the new XBB.1.5 formulation.
Beginning in the fall of 2023 for those previously vaccinated against COVID-19, individuals aged 6 months and older are recommended to receive a dose of the new formulation of COVID-19 vaccine if it has been at least 6 months from the previous COVID-19 vaccine dose or known SARS-CoV-2 infection (whichever is later).
Immunization is particularly important for those at increased risk of COVID-19 infection or severe disease, for example:
- Adults 65 years of age or older
- Residents of long-term care homes and other congregate living settings
- Individuals with underlying medical conditions that place them at higher risk of severe COVID-19
- Individuals who are pregnant
- Individuals in or from First Nations, Métis and Inuit communities
- Members of racialized and other equity-deserving communities
- People who provide essential community services
|
|
Approved COVID-19 mRNA vaccine for primary series |
Time between doses of primary series/# of doses |
Time between last dose received and additional dose |
Approved COVID-19 mRNA vaccines for additional doses for fall 2023 |
|
Individuals aged |
Moderna/Spikevax™ XBB.1.5 (25mcg) |
N/A 1 dose |
6 months |
Moderna/Spikevax™ XBB.1.5 (25mcg) |
|
Individuals aged |
Moderna/Spikevax™ XBB.1.5 (50mcg) |
N/A 1 doses |
6 months |
Moderna/Spikevax™ XBB.1.5 (50mcg) |
Novavax/Nuvaxovid™, if available, is a different type of COVID-19 vaccine that may be offered to adults 12 years and older who are unable or unwilling to receive a COVID-19 mRNA vaccine.
For more information on the National Advisory Committee on Immunization (NACI) recommendations, please go to the Canadian Immunization Guide
Vaccine Eligibility for Infants, Children, Youth and Adults who are Moderately to Severely Immunocompromised
For the purposes of COVID-19 vaccine recommendations, the following individuals are considered moderately to severely immunocompromised due to a medical condition and/or treatment:
- are receiving active chemotherapy (or immunotherapy) for cancer;
- have received a solid organ transplant and are currently receiving chemotherapy or other immunosuppressive therapy;
- were born with moderate or severe dysfunction of their immune system;
- are living with untreated or advanced HIV-AIDS; or
- are taking certain medications that severely affect the immune system.
The following people should talk to their doctor to see whether they are considered to be immunocompromised:
- receiving hemodialysis or peritoneal dialysis;
- are on the list to receive a solid organ transplant; or
- have a ventricular assist device (VAD).
The COVID-19 mRNA vaccines are the preferentially recommended COVID-19 vaccines. Your health care provider may recommend a different immunization schedule for you based on a review of your medical history and individual circumstances.
If not previously immunized or if partially immunized against COVID-19:
- Individuals six months to four years of age who are moderately to severely immunocompromised are eligible to receive three doses of the Moderna/Spikevax™ vaccine or four doses of the Pfizer/Comirnaty™ vaccine. The Moderna vaccine is preferred due to quicker protection from a three dose series.
- Individuals five years of age and older who are moderately to severely immunocompromised are recommended to receive three doses of COVID-19 vaccine. The interval between the first and the second dose is four to eight weeks.
- Individuals who started their primary series with the original monovalent or bivalent vaccines can complete their primary series with the updated XBB.1.5 formulation. Regardless of which product was used to start a primary series, the previous dose(s) should be counted and the series need not be restarted.
If having previously completed a COVID-19 vaccine primary series:
- Individuals six months of age and older who are moderately to severely immunocompromised are recommended to receive a dose of the updated XBB.1.5 formulation in the fall of 2023 if it has been at least 6 months from the previous COVID-19 vaccine dose or known SARS-CoV-2 infection (whichever is later).
|
|
Approved COVID-19 mRNA vaccine for primary series |
Immunosuppressed: Time between doses of primary series/# of doses |
Time between last dose received and additional dose |
Approved COVID-19 mRNA vaccines for additional doses for fall 2023 |
|
Infants and children aged 6 months to 4 years |
Moderna/Spikevax™ XBB.1.5 (25mcg) or Pfizer/Comirnaty™(3mcg) |
+Moderna: 4 to 8 weeks between each dose/3 doses Pfizer: 4 to 8 weeks between each dose/4 doses |
6 months |
Moderna/Spikevax™ XBB.1.5 (25mcg) |
|
Individuals aged 5 years to 11 years |
Moderna/Spikevax™ XBB.1.5 (50mcg) |
4 to 8 weeks between each dose/3 doses |
6 months |
Moderna/Spikevax™ XBB.1.5 (50mcg) |
|
Individuals aged |
Moderna/Spikevax™ XBB.1.5 (50mcg) |
4 to 8 weeks between each dose/3 doses |
6 months |
Moderna/Spikevax™ XBB.1.5 (50mcg) |
+ Moderna/Spikevax™ is the recommended mRNA vaccine for Immunocompromised Infants and children 6 months to 4 years.
Immunization after a COVID-19 infection
It is recommended to wait six months before getting your next dose of COVID-19 vaccine after a known SARS-CoV-2 infection.
Recommendations may be different if you are moderately to severely immunocompromised. Please speak to your health care provider to get the best advice on when to get your next vaccine dose after a COVID-19 infection.
For more information on NACI's recommendation on interval between infection and getting your next COVID-19 vaccine dose, please visit: COVID-19 vaccine: Canadian Immunization Guide - Canada.ca.
Organizing a Workplace Clinic
Manitoba expanded access to workplaces to help their staff get immunized against COVID-19.
There are a number of ways that workplaces can coordinate immunizations.
- Employers with occupational health services that normally include immunization or intramuscular injections can apply to the Independent Immunization Partner (IIP) program. This allows them to order and administer COVID-19 vaccines similar to a seasonal flu campaign. Visit this page for more information and to apply.
- Employers can arrange to have vaccinations provided on site with a participating pharmacy or medical clinic. Employers and can reach out directly to make arrangements.
- Group bookings are available at vaccine clinics located throughout the province.
- If a medical clinic or pharmacy isn't available, employers can contact their regional health authority and request a focused immunization team to come on site and administer vaccines on a particular day.
| Region | Contact |
| Interlake-Eastern Regional Health Authority |
Wendy Fontaine wfontaine@ierha.ca |
| Northern Regional Health Authority |
Leslie Sraybash lsraybash@nrha.ca |
| Prairie Mountain Health |
Jane Skinner jskinner@pmh-mb.ca |
| Southern Health-Santé Sud |
Loreley Fehr lfehr3@southernhealth.ca |
| Winnipeg Regional Health Authority |
Donna Jacobs DJacobs@wrha.mb.ca |
Workplace COVID-19 Resources for Employers and Workplaces
https://manitoba.ca/asset_library/en/covid/workplace-covid-documents.pdf
How to Report your COVID-19 Vaccine and Update your Immunization Records
If you received a COVID-19 vaccine outside of Manitoba, you should report them so your Manitoba immunization record is up to date. In order to do this, you will need proof of immunization from the jurisdiction where you received your vaccine. Once you have your vaccination record that needs to be added, please use this online form to submit it, and your information will be updated once your immunization record is validated. You will be notified once your immunization record is updated. After your information has been updated, you can request your immunization record online.
The e-form process will make it faster and easier to make changes to your vaccination record. It will also help your primary care physician and our public health teams to view your full immunization history. Alternatively, people can call 1-844-MAN-VACC (1-844-626-8222) and follow the call centre prompts to get the update process started.
Immunization Records
In order to show your immunization status, residents of Manitoba can request a Canadian Proof of Vaccination Credential (PVC) (valid throughout Canada and internationally). As of March 1, 2022, Manitoba's proof of vaccination requirement is no longer mandatory.
Canadian Proof of Vaccination Credential (PVC)
The Canadian COVID-19 Proof of Vaccination Credential (PVC) is a secure and reliable way to show your proof of COVID-19 vaccination history. The only medical information contained in this document is related to your COVID-19 vaccination history. The PVC, and associated QR code, contains your name, date of birth, date of immunization, brand of vaccine received and lot number. If your information is scanned by a verifier app it will be subject to open data collection.
The PVC can be used for travel within Canada and internationally and is a recognized and trusted document with international partners. It is important to confirm the immunization requirements for your travel destination and any stops along the way before departing to confirm what type of proof is accepted.
Request Your PVC
You can request your PVC online at immunizationcard.manitoba.ca or through the Manitoba Immunization Card app available in the Apple App Store or on Google Play. You can also call the province's call centre at 1 844 MAN VACC (1 844 626 8222) for more information about the process. Your PVC will contain any international COVID-19 vaccines you received if they are part of Health Canada's accepted list of World Health Organization (WHO) approved COVID-19 vaccines. The list of WHO approved COVID-19 vaccines can be found at: COVID-19 Vaccines with WHO Emergency Use Listing | WHO - Prequalification of Medical Products (IVDs, Medicines, Vaccines and Immunization Devices, Vector Control). If you received a vaccine that is not on the accepted list, it may still appear on the PVC but with limited information.
The PVC is available digitally on your smart phone/device or you can select to receive it by email and you can then print a hard copy of the PDF. If you would like to have your PVC available on multiple devices, you must request the PVC on each individual device. The app only stores the information for your PVC while you are logged in. Once logged out, the app will erase your PVC. You will have to request it again the next time you log in. It is NOT available as a wallet certificate at this time.
The PVC follows the SMART Health Card standard. It provides a safe and secure way to share limited information about your COVID-19 vaccination history. Any scanner that has the ability to read a SMART Health Card QR code will be able to read the QR code on your PVC. You can keep a digital copy of your proof of vaccination on any smart phone/device.
More information on the PVC and SMART Health Cards is available at canada.ca/en/public-health/services/diseases/coronavirus-disease-covid-19/vaccines/vaccine-proof.html
Immunization Records (All vaccinations)
An immunization record is a personal medical record used by the provincial health care system that identifies the vaccinations that you have received that were recorded by health care providers in Manitoba.
Manitobans can access their own COVID-19 immunization records online, which show the dates you received COVID-19 vaccines and the type of vaccines received. It is helpful to know when you received your previous doses of COVID-19 vaccine and the type of vaccine you received. If you do not recall this information and you have a Manitoba health card, you can locate it at: sharedhealthmb.ca/covid19/test-results/. If your immunization record is incomplete or incorrect, or you received a COVID-19 vaccination outside of Manitoba, you can have your file updated by completing and submitting this e-form.
For a copy of your full immunization record, please contact your local public health office. Further information on immunization records can be found at: Your Immunization Record Matters | Communicable Disease Control | Public Health | Manitoba Health | Province of Manitoba (gov.mb.ca)
Please be aware that your immunization record, including the COVID-19 immunization record, may not be an acceptable form of proof of vaccination for the purposes of travel. It is recommended to obtain your Canadian Proof of Vaccination Credential (PVC) for travel purposes.
Other important information
For information additional information on vaccine risk and intended benefits, please refer to the Provincial factsheets
Canada's National Advisory Committee on Immunization (NACI) makes COVID-19 vaccine specific recommendations for people of all ages. These recommendations and guidance from NACI are available here.
Vaccine finder
The Manitoba COVID-19 & Influenza Vaccine Finder is an online service where the public can search for locations that offer either the COVID-19 vaccine or influenza vaccine in their area.
Providers are actively working to update vaccine availability on the Manitoba Vaccine Finder.
For COVID-19 Vaccine, please check the Current COVID-19 Vaccine Eligibility Criteria.
For more information on the Manitoba Influenza Vaccine Program, including eligibility criteria, please visit www.manitoba.ca/flu
NOTE: where there are multiple providers at the same address, they will all show up on the same dot on the map. Once the dot has been clicked on, use the arrow buttons to toggle between the different providers at that address.
View the map in a separate window
For Immunization Providers:
Please remember to keep how your location appears on the map current by visiting https://forms.office.com/r/fZh8GGdJgQ.
Data from this source will be used to update the map daily from Monday to Friday.
If you notice an error in the information presented on the map, please email COVID@gov.mb.ca* and remember to include your client ID in any communications.
*This email address is for communications from immunization providers only. Emails from members of the public will not be returned. Please direct any of your questions or concerns to Ask Health by filling out the following form: https://forms.gov.mb.ca/Ask_Health/
